Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野生物医学と臨床科学腫瘍学とがん発生予測・予測マーカー
未知の原発性がんにおけるSMARCA4に焦点を当てたSWI/SNF染色体改造異常の臨床病理学的および遺伝子解析

未知の原発性がんにおけるSMARCA4に焦点を当てたSWI/SNF染色体改造異常の臨床病理学的および遺伝子解析

Yasutaka Tono ¹, Koshi Sukeno ², Akira Tsunoda ², Mariko Okayama ³, Hiroki Oka ², Hiroyasu Oda ³, Kanako Saito ², Yoshiki Yamashita ², Masayasu Taniguchi ³, Makoto Ikejiri ⁴, Satoshi Tamaru ⁵, Masaki Tanabe ⁴, Hiroshi Imai ⁶, Masatoshi Watanabe ⁷, Toshiro Mizuno ²

Yasutaka Tono ¹, Koshi Sukeno ², Akira Tsunoda ²

¹Department of Medical Oncology, Mie University Hospital, 2-174, Tsu, 514- 8507, Mie, Japan. ytono@med.mie-u.ac.jp.
²Department of Medical Oncology, Mie University Hospital, 2-174, Tsu, 514- 8507, Mie, Japan.
³Department of Medical Oncology, Ise Red Cross Hospital, Mie, 516-8512, Ise, Japan.
⁴Department of Clinical Laboratory, Mie University Hospital, Tsu, 514-8507, Japan.
⁵Clinical Research Support Center, Mie University Hospital, Tsu, 514-8507, Japan.
⁶Pathology Division, Mie University Hospital, Tsu, 514-8507, Mie, Japan.
⁷Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan.

⁰Department of Medical Oncology, Mie University Hospital, 2-174, Tsu, 514- 8507, Mie, Japan. ytono@med.mie-u.ac.jp.

Journal of Cancer Research and Clinical Oncology +

|

2025年8月27日

関連する実験動画

These videos have been matched automatically. Contact us if they are not relevant.

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

See all related videos

PubMedで要約を見る

まとめ

この要約は機械生成です。

SWI/SNF染色体改造異常,特にSMARCA4欠乏症は,未知の原発がん (U-CUP) と関連している. SMARCA4欠乏症は,CUP患者の免疫チェックポイント阻害剤 (ICI) 治療による改善を予測する可能性がある.

科学分野

腫瘍学
遺伝学
分子生物学

背景

主要腫瘍の部位を推定することは,未知の原発がん (CUP) の化学療法を選択する上で極めて重要です.
ゲノム検査とバイオマーカーによる治療は,CUP,特に未分類または未知の組織学的タイプ (U-CUP) に対して,標的薬剤と免疫チェックポイント阻害剤 (ICI) を導くために不可欠です.
SWI/SNF複合体は,クロマチンの重要な調節体であり,様々な癌に頻繁に関与しています.

研究の目的

SWI/SNF染色体改造異常に関連するCUPの臨床的特徴を調査する.
CUPにおけるICI有効性の予測マーカーとしてSWI/SNF異常が機能するかどうかを判断する.
SMARCA4欠乏症とU-CUPとの関連を調査する.

主な方法

2009年1月から2022年3月までの80人のCUP患者を対象とした観察研究です.
SMARCA2,SMARCA4,およびSMARCB1のタンパク質発現を評価するために免疫ヒストロケミストが使用されました.
32人のCUP患者で,SWI/SNF関連遺伝子 (SMARCA4,SMARCA2,SMARCB1,ARID1A,PBRM1,ARID2,ARID1B) の次世代配列解析を行った.

主要な成果

CUP患者の17. 5%でSMARCA4タンパク質の減少が観察された.
SMARCA4変異は,CUP配列の50%の患者で発見され,その中断変異はタンパク質喪失と相関していた.
SMARCA4欠乏症はU- CUPの症例と関連しており,ICIを含む治療法はSMARCA4欠乏症の患者で全生存期間を改善した.

結論

SWI/SNF染色体改造異常はCUPに存在しています.
SMARCA4欠乏症はU- CUPと関連しており,ICI治療の選択における潜在的予測マーカーを示唆する可能性がある.
この研究は,SMARCA4欠乏症のU-CUPの治療のためのバイオマーカー主導の戦略を強調しています.

キーワード:

原因不明の原発がんクロマチンの改造 SMARCA4 について SWI/SNF について

関連する実験動画

自動的に一致したビデオです Contact us もしそれらが関連していない場合

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

See all related videos

関連する概念動画

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies